Serum dopamine-beta-hydroxylase activity and alcohol withdrawal symptoms.
Fifty male alcoholics had serum dopamine-beta-hydroxylase (DBH) activity, and serum prolactin (PRL) levels measured on the day of withdrawal, and 22 of them also on days 7 and 28 after it. The obtained values were related to the development of withdrawal symptoms. Treatment was begun with meprobamate on the first day of withdrawal, and from day 7 it was completed with disulfiram (250 and 500 mg/day, respectively). Serum DBH activity decreased significantly by day 7, however a further fall of it occurred by day 28 only in patients receiving high doses (500 mg) of disulfiram. PRL levels rose over the period of withdrawal which reached significance level on day 28. No correlation was found between serum DBH activity and the severity of withdrawal symptoms. Serum DBH activity did not differ from that of the healthy controls at either point of time, while serum PRL level was significantly elevated throughout the period of the study.
D000328:Adult; D000437:Alcoholism / Q000097:blood / Q000201:enzymology; D004299:Dopamine beta-Hydroxylase / Q000097:blood*; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000201:enzymology*
D000431:Ethanol; D011388:Prolactin; D004299:Dopamine beta-Hydroxylase